December 7, 2009 (FinancialWire) — NeoGenomics, Inc. (OTCBB: NGNM) has appointed Steven C. Jones as executive vice president, Finance and that George A. Cardoza has joined the company as chief financial officer.

Cardoza will be responsible for managing all internal financial affairs of the company. In his new role, Jones will focus on developing strategic initiatives on behalf of NeoGenomics as well as continue to serve as the company’s director of Investor Relations.

Cardoza most recently served as chief financial officer of Protocol Global Solutions, a privately held international marketing company. Prior to joining Protocol Global Solutions in 2006, Cardoza was employed by Quest Diagnostics in a range of financial roles.

NeoGenomics is a clinical laboratory that specializes in cancer genetics diagnostic testing. Headquartered in Fort Myers, Florida, NeoGenomics has labs in Nashville, Tennessee, Irvine, California and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.